Poseida Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-03. The offering totals $15.0M, of which $11.2M was reported sold. Industry: Biotechnology.
Showing 25 of 37 people.
| Name | Role | Location |
|---|---|---|
| Nishan de Silva | Director | San Diego, CA |
| Lars Ekman | Director | San Diego, CA |
| Robert Lyons | Director | Grand Cayman, E9 |
| Nishan de Silva | Executive Officer | San Diego, CA |
| Brent J Warner | Executive Officer | SAN DIEGO, CA |
| Mark Gergen | Director | San Diego, CA |
| Mark Gergen | Executive Officer | San Diego, CA |
| Mark Gergen | Related Person | San Diego, CA |
| John Schmid | Related Person | San Diego, CA |
| Sean Murphy | Related Person | San Diego, CA |
| Charles M Baum | Director | Boston, MA |
| Harry J Leonhardt | Executive Officer | San Diego, CA |
| Mark J Gergen | Director | San Diego, CA |
| Mark J Gergen | Executive Officer | San Diego, CA |
| Johanna M Mylet | Executive Officer | San Diego, CA |
| Luke M Corning | Director | San Diego, CA |
| Cynthia M Collins | Director | San Diego, CA |
| Marcea B Lloyd | Director | San Diego, CA |
| Kristin J Yarema | Executive Officer | San Diego, CA |
| John B Schmid | Director | San Diego, CA |
| Rafael J Amado | Director | San Diego, CA |
| David Hirsch | Director | San Diego, CA |
| David Hirsch | Related Person | San Diego, CA |
| John J Schmid | Director | San Diego, CA |
| Noah J Berkowitz | Director | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2023-08-11 | D | $25.0M | $25.0M |
| 2019-04-22 | D | $150.0M | $142.1M |
| 2018-04-03 | D | $30.5M | $30.5M |
| 2015-12-24 | D | $36.0M | $23.0M |